Filgotinib Has Become Great News for Gilead Sciences and Galapagos NV

Impacting News October 12, 2020

Gilead and Galapagos Granted Marketing Authorization for Filgotinib by the EC
Gilead Sciences (GILD) and Galapagos NV (This content is for paid subscribers.

Please click here to subscribe or here to log in.

Impacting News
Galapagos NV (GLPG), Gilead Sciences (GILD)
October 12, 2020

Tweet Pin It

Other Articles

Johnson & Johnson Expands U.S. Footprint With More Than $1 Billion Investment In Next Generation Cell Therapy Manufacturing Facility in Pennsylvania

February 19, 2026 0

Bio-Techne Corp Releases Second Quarter Fiscal 2026 Results

February 5, 2026 0

Corcept Therapeutics: Overall Survival Primary Endpoint Met In Pivotal Phase 3 Rosella Trial OF Relacorilant in Patients With Platinum-Resistant Ovarian Cancer

January 26, 2026 0

Bristol-Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer

January 22, 2026 0

Search ProhostBiotech

Popular Links
Aerie Pharmaceuticals (AERI) Agenus (AGEN) Alnylam Pharmaceuticals (ALNY) Amgen (AMGN) Array BioPharma (ARRY) AstraZeneca Plc (AZN) Bellicum Pharmaceuticals Inc (BLCM) Bristol-Myers Squibb (BMY) Celgene (CELG) Celldex Therapeutics (CLDX) Cellectis (CLLS) Celyad (CYAD) Compugen (CGEN) CRISPR Therapeutics (CRSP) CytomX Therapeutics Inc (CTMX) Editas Medicine Inc (EDIT) Enanta Pharmaceuticals (ENTA) Exelixis (EXEL) Gilead Sciences (GILD) Halozyme Therapeutics (HALO) Illumina (ILMN) ImmunoGen (IMGN) Incyte (INCY) Innoviva (INVA) Intellia Therapeutics (NTLA) Ionis Pharmaceuticals Inc (IONS) Karyopharm Therapeutics Inc (KPTI) Merck (MRK) Moderna Inc (MRNA) Nektar Therapeutics (NKTR) Neurocrine Biosciences (NBIX) Novartis (NVS) Portola Pharmaceuticals Inc (PTLA) PTC Therapeutics (PTCT) Regeneron Pharmaceuticals (REGN) Regenxbio (RGNX) Rhythm Pharmaceuticals Inc (RYTM) Sangamo Therapeutics Inc (SGMO) Sarepta Therapeutics (SRPT) Seagen Inc (SGEN) Spark Therapeutics Theravance Biopharma (TBPH) Vertex Pharmaceuticals (VRTX) Xoma (XOMA)

Recent

ProhostBiotech Archive
ProhostBiotech Archive
Sign Up for Weekly Emails
First Name

Last Name

Email address:

Prohost Biotech – Exclusive Biotech Research Copyright © 2026.
© 2014 Prohost Biotech. All rights reserved.
Privacy Policy | Cancellation Policy | Forward Looking Statement

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Exclusive Market Insight

& Scientific analysis

Filgotinib Has Become Great News for Gilead Sciences and Galapagos NV